English
Specials
    Upgrade

    Moneycontrol

    Budget 2023Budget 2023

    PARTNERS

    • Tata AIA Life Insurance
    • Hafele
    • Motilal Oswal
    • SMC Global Securities Limited
    • SBI Life
    • DSP Mutual Fund
    Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
    you are here: HomeNewsOpinion

    Divi’s and Gland Pharma’s weak results show B2B model not without risks

    Post the weak September quarter results, analysts fear revenue may decline at both the companies in FY23

    R. Sree Ram
    November 10, 2022 / 11:28 AM IST
    Divi’s and Gland Pharma’s weak results show B2B model not without risks

    Highlights Divi’s clocked its first quarterly sales drop in years. Gland Pharma saw steady decline in profit margins Performance hit by high costs, delay in projects and slowing COVID drug sales Companies are adding new projects and capacities whose benefits are expected to materialise from the next fiscal year or so  Divi’s Laboratories and Gland Pharma, which thrived on the business to business (B2B) model, have hit a speed breaker. Shares of both these companies slumped after the September quarter results. Divi’s clocked...

    • PRO Panorama

      Moneycontrol Pro Panorama | Will the MPC signal a pause? 

      Feb 6, 2023 / 03:05 PM IST

      In today’s edition of Moneycontrol Pro Panorama: Market outlook for automakers gets a lift, will GST Council come up with wider ...

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers